The protective effects of ritodrine against hypoxia/reoxygenation-induced injury in endometrial stromal cells
article
OA: diamond
CC0
⤵ 2 in-corpus citations
AI-generated summary
Ritodrine ameliorated hypoxia/reoxygenation-induced injury in human endometrial stromal cells by inhibiting the ER-α/NF-κB pathway and reducing oxidative stress and inflammation.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Endometriosis (EMS) is often observed in women of childbearing age and significantly impacts patients' quality of life. Ritodrine is a β2 receptor agonist applied for relaxing the uterine smooth muscle. Its inhibitory effects on inflammation have recently been noted. The present study explored the protective impact of Ritodrine on hypoxia/reoxygenation (H/R)- induced injury in endometrial stromal cells (ESCs). Human ESCs (HESCs) were treated with Ritodrine (0.1, 0.5 μM) for 24 h, followed by exposure to H/R for 6 h. Ritodrine ameliorated H/R-induced higher reactive oxygen species (ROS), declined glutathione (GSH) concentration and increased production of tumor necrosis factor-α (TNF-α), interleukin- 6 (IL-6), and monocyte chemotactic protein 1 (MCP-1) in HESCs. Furthermore, Ritodrine ameliorated the H/R-induced higher nuclear level of nuclear factor κ-B (NF-κB) p65 expression and increased luciferase activity of the NF-κB promoter. In addition, we show that Ritodrine mitigated H/R-induced higher estrogen receptor α (ER-α) expression in HESCs. Interestingly, overexpressing ER-α abolished the regulatory effects of Ritodrine on oxidative stress and the NF-κB pathway-mediated inflammation. Collectively, our data reveal that Ritodrine alleviated H/R-induced injury in ESCs by inhibiting the ER-α/NF-κB pathway.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (41)
- Chronic stress accelerates the development of endometriosis in mouse through adrenergic receptor β<sub>2</sub> via openalex
- Cytokines, Angiogenesis, and Extracellular Matrix Degradation are Augmented by Oxidative Stress in Endometriosis via openalex
- Early Endometriosis in Females Is Directed by Immune-Mediated Estrogen Receptor α and IL-6 Cross-Talk via openalex
- Endometriosis: the pathophysiology as an estrogen-dependent disease via openalex
- ESHRE guideline for the diagnosis and treatment of endometriosis via openalex
- Evaluation of oxidative stress markers and intra-extracellular antioxidant activities in patients with endometriosis via openalex
- Hypoxia-inducible factor-1α promotes endometrial stromal cells migration and invasion by upregulating autophagy in endometriosis via openalex
- Importance portance of reactive oxygen species in the peritoneal fluid of women with endometriosis or idiopathic infertility via openalex
- Kinase signalling pathways in endometriosis: potential targets for non-hormonal therapeutics via openalex
- Local estrogen formation and its regulation in endometriosis via openalex
- Oxidative stress biomarkers in patients with endometriosis: systematic review via openalex
- Pathophysiology of Endometriosis: Role of High Mobility Group Box-1 and Toll-Like Receptor 4 Developing Inflammation in Endometrium via openalex
- Pharmaceuticals targeting signaling pathways of endometriosis as potential new medical treatment: A review via openalex
- Physiologic activation of nuclear factor kappa-B in the endometrium during the menstrual cycle is altered in endometriosis patients via openalex
- Protein oxidative stress markers in peritoneal fluids of women with deep infiltrating endometriosis are increased via openalex
- Serum markers of oxidative stress and endometriosis via openalex
- Targeting oxidative stress to treat endometriosis via openalex
- W3087617819 via openalex
- W3093231756 via openalex
- W3093525518 via openalex
- W3096770937 via openalex
- W3165291177 via openalex
- W3165891459 via openalex
- W1588312796 via openalex
- W4200449967 via openalex
- W1673385631 via openalex
- W1986917036 via openalex
- W1991952977 via openalex
- W2097325815 via openalex
- W2135935849 via openalex
- W2154377312 via openalex
- W2171929498 via openalex
- W2256575032 via openalex
- W2314870464 via openalex
- W2754055756 via openalex
- W2943360664 via openalex
- W3008044640 via openalex
- W3013888723 via openalex
- W3014625906 via openalex
- W3015778009 via openalex
- W3016339115 via openalex
Cited by (2)
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-06-04T00:34:36.779044+00:00
License: CC0
· commercial use OK